Allogeneic Hematopoietic Stem Cell Transplantation Recipient
📧 Sign up to get email alerts when something new happens for Allogeneic Hematopoietic Stem Cell Transplantation Recipient.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating denosumab for bone loss associated with donor stem cell transplant, completed with results posted in 2024.